Treatment of Peritoneal Carcinomatosis of Colorectal Origin
- 1 May 2015
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in American Society of Clinical Oncology Educational Book
- Vol. 35 (35) , e208-e211
Abstract
The management of peritoneal carcinomatosis from colon cancer remains a controversial issue. Peritoneal carcinomatosis is associated with worse survival and has led to an aggressive treatment that combines surgery and intraperitoneal chemotherapy (IPC). This review will describe the rationale behind this treatment and the current controversy surrounding it.Keywords
This publication has 20 references indexed in Scilit:
- Colon Cancer, Version 3.2014Journal of the National Comprehensive Cancer Network, 2014
- Recommendations for Bowel Obstruction With Peritoneal CarcinomatosisJournal of Pain and Symptom Management, 2014
- Identification of Potentially Avoidable Hospitalizations in Patients With GI CancerJournal of Clinical Oncology, 2014
- Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841Journal of Clinical Oncology, 2012
- Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144Clinical Colorectal Cancer, 2009
- A review of peritoneal mesothelioma at the Washington Cancer InstituteSurgical Oncology Clinics of North America, 2003
- Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix CancerAnnals of Surgical Oncology, 2001
- Peritonectomy ProceduresAnnals of Surgery, 1995
- Effect of hyperthermia on malignant cellsin vivo: A review and a hypothesisCancer, 1977
- Selective heat sensitivity of cancer cells. Biochemical and clinical studiesCancer, 1967